Ballentine Partners’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.78M Buy
6,447
+619
+11% +$171K 0.03% 214
2025
Q1
$1.55M Buy
5,828
+45
+0.8% +$11.9K 0.03% 218
2024
Q4
$1.34M Buy
5,783
+367
+7% +$85.2K 0.02% 236
2024
Q3
$1.2M Buy
5,416
+351
+7% +$77.4K 0.02% 249
2024
Q2
$996K Sell
5,065
-189
-4% -$37.2K 0.02% 262
2024
Q1
$1.13M Buy
5,254
+60
+1% +$12.9K 0.02% 219
2023
Q4
$1.09M Buy
5,194
+121
+2% +$25.5K 0.02% 219
2023
Q3
$1.02M Buy
5,073
+159
+3% +$31.8K 0.02% 199
2023
Q2
$911K Sell
4,914
-23
-0.5% -$4.26K 0.02% 208
2023
Q1
$946K Buy
4,937
+741
+18% +$142K 0.02% 199
2022
Q4
$706K Buy
4,196
+162
+4% +$27.2K 0.02% 227
2022
Q3
$714K Buy
4,034
+521
+15% +$92.2K 0.02% 192
2022
Q2
$719K Buy
3,513
+176
+5% +$36K 0.03% 188
2022
Q1
$793K Buy
3,337
+143
+4% +$34K 0.02% 198
2021
Q4
$730K Hold
3,194
0.02% 218
2021
Q3
$617K Sell
3,194
-29
-0.9% -$5.6K 0.02% 210
2021
Q2
$686K Buy
3,223
+14
+0.4% +$2.98K 0.02% 194
2021
Q1
$655K Buy
3,209
+114
+4% +$23.3K 0.02% 192
2020
Q4
$563K Sell
3,095
-564
-15% -$103K 0.02% 204
2020
Q3
$612K Sell
3,659
-3,127
-46% -$523K 0.03% 186
2020
Q2
$1.1M Buy
6,786
+4,091
+152% +$665K 0.05% 132
2020
Q1
$466K Buy
2,695
+987
+58% +$171K 0.03% 194
2019
Q4
$343K Buy
1,708
+86
+5% +$17.3K 0.02% 283
2019
Q3
$343K Buy
1,622
+12
+0.7% +$2.54K 0.02% 263
2019
Q2
$313K Buy
+1,610
New +$313K 0.02% 281
2019
Q1
Sell
-1,169
Closed -$220K 333
2018
Q4
$220K Buy
+1,169
New +$220K 0.01% 289